Geneesmiddelenbeleid

This procedure involves a report on written consultations regarding the pharmaceutical policy of the Netherlands. It focuses on how the government manages the availability, pricing, and accessibility of medicines to ensure public health standards are met. This affects healthcare providers, pharmaceutical companies, and patients who rely on the national medicine supply chain and reimbursement systems.